Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-18

Clinical Trial Update: The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer [NA]

View source ↗

Summary

Clinical trial update on the mechanism of action of the Unite Biomatrix in diabetic foot ulcers; the study is terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unite Biomatrix

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Diabetic Foot Ulcers | NA | Status: TERMINATED | Results posted: 2019-12-18